Correlation Between Regenicin and Biostage

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenicin and Biostage at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenicin and Biostage into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenicin and Biostage, you can compare the effects of market volatilities on Regenicin and Biostage and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenicin with a short position of Biostage. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenicin and Biostage.

Diversification Opportunities for Regenicin and Biostage

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Regenicin and Biostage is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regenicin and Biostage in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biostage and Regenicin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenicin are associated (or correlated) with Biostage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biostage has no effect on the direction of Regenicin i.e., Regenicin and Biostage go up and down completely randomly.

Pair Corralation between Regenicin and Biostage

If you would invest  420.00  in Biostage on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Biostage or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Regenicin  vs.  Biostage

 Performance 
       Timeline  
Regenicin 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenicin has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Regenicin is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Biostage 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biostage has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Biostage is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Regenicin and Biostage Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenicin and Biostage

The main advantage of trading using opposite Regenicin and Biostage positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenicin position performs unexpectedly, Biostage can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biostage will offset losses from the drop in Biostage's long position.
The idea behind Regenicin and Biostage pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas